

We report the association of CDH1/E-cadherin mutations with cleft lip, with or without cleft palate (CLP), in two families with hereditary diffuse gastric cancer (HDGC). In each family, the CDH/mutation was a splicing mutation generating aberrant transcripts with an in-frame deletion, removing the extracellular cadherin repeat domains involved in cell-cell adhesion. Such transcripts might encode mutant proteins with trans-dominant negative effects. We found that CDH1 is highly expressed at 4 and 5 weeks in the frontonasal prominence, and at 6 weeks in the lateral and medial nasal prominences of human embryos, and is therefore expressed during the critical stages of lip and palate development. These findings suggest that alteration of the E-cadherin pathway can contribute to human clefting.
| EMTREE drug terms: | uvomorulin |
|---|---|
| EMTREE medical terms: | adultarticlecell adhesioncleft lipcleft lip palateclinical articlecontrolled studydisease associationfemalegene mutationgenetic associationhereditary diffuse stomach cancerhumanlipmalenucleotide sequenceorganogenesispalatepriority journalprotein expressionprotein functionstomach cancertissue specificity |
| MeSH: | AdultCadherinsCleft LipCleft PalateDNA Mutational AnalysisGene Expression ProfilingHumansMutationPedigreeStomach Neoplasms |
GENBANK,
NM_004360(referenced)uvomorulin, 112956-45-3;
Cadherins
Frebourg, T.; Inserm U614, Faculty of Medicine, 22 Boulevard Gambetta, France;
© Copyright 2008 Elsevier B.V., All rights reserved.
© MEDLINE® is the source for the MeSH terms of this document.